发明名称 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
摘要 The present invention relates to novel compositions and therapeutic methods for the treatment of cancer, in particular malignant glioma. The compositions include antisense oligonucleotides or RNAs or vectors encoding them which reduce expression of downregulated in renal cell carcinoma (DRR) in tumor cells, and inhibit malignant glioma cell invasion.
申请公布号 US8765708(B2) 申请公布日期 2014.07.01
申请号 US201113698429 申请日期 2011.05.18
申请人 发明人 Petrecca Kevin;Damha Masad;Deleavey Glen Francis
分类号 C12N15/11;C12Q1/68;C12N15/113 主分类号 C12N15/11
代理机构 Norton Rose Fulbright Canada 代理人 Norton Rose Fulbright Canada
主权项 1. An antisense oligonucleotide or RNA for reducing the expression of downregulated in renal cell carcinoma (DRR) in tumor cells, comprising the nucleotide sequence: 5′ A-A-T-G-T-C-T-G-C-C-C-G-C-T-C-C-C-T-C-T 3′ (SEQ ID NO: 16)wherein said antisense oligonucleotide or RNA comprises phosphorothioate internucleotide linkages.
地址